04/2019 Ventures

News adivo

adivo signs first major collaboration agreement with Bayer Animal Health to jointly develop species-specific therapeutic monoclonal antibodies to address the demand for innovative pet therapies. We congratulate adivo on this major step and look forward to further successful collaborations.


03/2019 Ventures

News Implandata

Congratulations to our portfolio company Implandata Ophthalmic Products on the CE certification of the EYEMATE-IO 1.1 microsensor implant for continuous monitoring of intraocular pressure in glaucoma patients! Market entry can thus take place in April 2019.


03/2019 Ventures

News Resistell

According to the Swiss business magazine Bilan, our portfolio company Resistell is one of the 50 start-ups in which to invest in 2019. We agree and congratulate Resistell!

More about Resistell

03/2019 Team

New Investment Analyst

Occident welcomes Dr. Kathrin Chojnowska to the team. Following her PhD in neurobiology, Kathrin joins the life sciences team as an Investment Analyst and supports Cédric Barra with her extensive expertise.

02/2019 Human Resources

Be part of tomorrow

We’re shaping the future, not just watching it happen. We invest in ground-breaking innovations before they change our lives forever. Are you intrigued by the opportunity to really have an impact in your job and accomplish something meaningful? Join us as a Junior Investment Manager and help shape the future!

More about Junior Investment Manager High-tech

More about Junior Investment Manager Digital

02/2019 Philanthropy

Fostering talents

Occident is the proud partner of the Co-Operaid Talents Program and this year again supports 25 disadvantaged students in Laos, Cambodia and Bangladesh with scholarships. This enables these young, highly motivated people to make their dreams come true and to create sustainable added value for the society, often disadvantaged ethnic minorities of the respective country, through their education.

In 2018, the Talents Program produced the first graduate, a lawyer from Bangladesh.

More about the Co-Operaid Talents Program

02/2019 Group

Tomorrow happens in Germany

In recent years, Occident has intensified its investment activities in Germany and we are now ready to take the next step by establishing our own branch office in Munich. We believe that Munich is a great location for our business, thanks to its top international universities and global technology leaders, along with a solid network of renowned investors.

Our goal is clear: we will press on and deepen our existing investment strategy in Germany, by reinforcing and expanding our investment team there as well.

02/2019 Ventures

News Lunaphore

Congratulations to our portfolio company Lunaphore for the launch of its first product LabSat™ for research applications!


Show more